Greece pulls every in-date batch of Steriflush saline syringes from the market

Greece's National Organization for Medicines (EOF) has ordered a market-wide withdrawal of the medical device Steriflush saline syringes (sodium chloride 0.9%). The notice was published on 9 November 2026 under protocol number 130053. It covers every batch of the product that has not yet reached its expiry date.

For anyone holding stock in Greece, the commercial consequence is direct: affected product is to come off the market, and the batches concerned are listed in a table attached to the decision. The notice does not say how many lots or units are involved, so the scale of the financial exposure cannot be gauged from what EOF has published.

The regulator's text does not give a reason for the recall. It does not say whether the trigger was a quality defect, a safety concern or something else, and it names no manufacturer and mentions no reported incidents. Without that, it is unclear whether the action is likely to stay confined to Greece or whether it signals a wider problem with the product.

Context: recalls of this kind typically fall on distributors, hospitals and other healthcare facilities holding the product, as well as on the supplier. Questions on that front, including supply continuity and any alternative products, are not addressed in EOF's notice.